Systemic and inhaled quinolone and fluoroquinolone antibiotics - Important Safety Information from the Marketing Authorisation Holders of fluoroquinolones as approved by the HPRA

Notice type: 3rd Party Publications

Date: 09/04/2019

Important Safety Information communication from the Marketing Authorisation Holders of fluoroquinolones: Systemic and inhaled quinolone and fluoroquinolone antibiotics - risk of disabling, long-lasting and potentially irreversible side effects and restrictions on use

Important Safety Information - Systemic and inhaled quinolone and fluoroquinolone antibiotics